Navigation Links
GranuFlo Lawsuit Filings Near 2,000 in Federal Massachusetts Litigation Two Years after Dialysis Recall, Bernstein Liebhard LLP Reports
Date:7/20/2014

New York, NY (PRWEB) July 20, 2014

Nearly 2,000 NaturaLyte and GranuFlo lawsuits (http://www.thegranuflolawsuit.com ) have now been filed in a federal litigation involving the dialysis medications, Bernstein Liebhard LLP reports.

A Case List updated on July 15th indicates that 1,942 lawsuits are now pending in the U.S. District Court, District of Massachusetts, where a federal proceeding is underway. All lawsuits in this litigation were filed after the U.S. Food and Drug Administration (FDA) issued a Class I recall of GranuFlo and NaturaLyte due to their alleged potential to cause serious cardiovascular events. According to plaintiffs, these may include heart attacks, strokes and sudden cardiac death. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“Our Firm is representing numerous clients now involved in the federal GranuFlo proceeding underway in Massachusetts, and we continue to speak with individuals whose loved ones were allegedly harmed by the dialysis medications,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free and confidential GranuFlo lawsuit evaluations to individuals who allegedly suffered serious heart injuries after taking the dialysis drugs.

GranuFlo Lawsuits
According to court documents in the District of Massachusetts, plaintiffs in GranuFlo and NaturaLyte lawsuits similarly accuse Fresenius of failing to adequately warn dialysis patients and their doctors about injuries that may stem from its products. Plaintiffs further allege that the companies continued to promote its products even after becoming aware of risks.

On March 29, 2012, Fresenius issued an Urgent Product Notification that warned of GranuFLo and NaturaLyte’s association with metabolic alkalosis, a condition that may be associated with serious heart problems. This may be caused by the medications’ elevated amount of an ingredient the body converts to bicarbonate. Two months later, the FDA announced a Class I recall of the medications after finding that hundreds of people suffered cardiovascular injuries after taking GranuFlo and NaturaLyte.

A New York Times report published shortly after the June 2012 recall indicates that the FDA was investigating Fresenius Medical Care, after finding that the company knew about hundreds of patient deaths that followed use of the medications.*

Individuals who allegedly suffered heart attacks, strokes, or other life-threatening heart events within 72 hours of using GranuFlo and NaturaLyte in dialysis may be entitled to compensation for their injuries. Learn more about lawsuits filed after the GranuFlo recall when you visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.

*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.thegranuflolawsuit.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/granuflo-recall/prweb12030636.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
2. GranuFlo Lawsuits Move Forward, as Federal Court Adopts Master Complaint for all Claims Filed in Wake of GranuFlo and NaturaLyte Recall, Bernstein Liebhard LLP Reports
3. Federal GranuFlo Lawsuits Move Forward with Scheduling of First Status Conference of the New Year, Bernstein Liebhard LLP Reports
4. Bernstein Liebhard LLP Publishes New GranuFlo Lawsuit Website for Individuals Allegedly Affected by 2012 Dialysis Drug Recall
5. GranuFlo Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Joint Motion in Federal GranuFlo Recall Litigation
6. More Than 430 Cases Now Filed in Federal GranuFlo Lawsuit Litigation, Bernstein Liebhard LLP Continues to Investigate Dialysis Claims
7. Bernstein Liebhard LLP Launches New GranuFlo Lawsuit Website for Individuals Allegedly Injured by Recalled Dialysis Medications
8. GranuFlo, NaturaLyte, Heart Attack Allegation Attorneys: Resource4thePeople Comments on New Developments in Consolidated Federal Litigation
9. Federal GranuFlo Lawsuits Progress, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in GranuFo Recall Litigation
10. GranuFlo Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Dialysis Lawsuits Against Fresenius Medical Care
11. GranuFlo Lawsuits Mount, as Filings in Federal GranuFlo Recall Litigation Approach 400, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... behind the New England Journal of Medicine and NEJM Journal Watch, announces the ... Board Review was created by a panel of pediatricians from leading medical centers. ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... comprehensive weight management program at Women’s Excellence will help patients lose weight and ... physical exam. The specialists at Women's Excellence will measure BMI, body fat ...
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still in shock ... the best days I’ve had in a long time,” she said. , She thinks the ... of money that I never thought I would have to help my students.” , The ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy ... resolve the pending litigation between itself and 1800 Vending DBA Healthy You Vending. ... “I am thrilled to announce that we have now reached a settlement agreement ...
(Date:3/26/2017)... ... 2017 , ... Local physician Dr. Justin Harper is one ... honoring the top influencers on RealSelf—the most trusted online destination to get informed ... , In 2016, more than 82 million people visited RealSelf to research cosmetic ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Cota Healthcare, the ... precision medicine, today announced the signing of ... Corporation to help improve clinical and cost ... As part of this agreement, which expands ... into January 2016, teams from across Novartis ...
(Date:3/24/2017)... Research and Markets has announced the ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report ... cell therapy manufacturing and focuses both on contract manufacturers and ... anticipated to emerge as viable alternatives to conventional treatment options. ...
(Date:3/24/2017)... and Markets has announced the addition of the "Global Wound Care ... to their offering. ... global wound care market was worth $24,482.9 million in 2015 and it ... Among the various wound care products type, the advanced wound care ... Among the various applications, surgical wound segment held the largest share in ...
Breaking Medicine Technology: